Voyager Therapeutics, Inc. (VYGR) Thursday said it appointed Nathan Jorgensen as Chief Financial Officer, effective July 8.
Most recently, Jorgensen served as the finance chief at Vor Bio, where he was in charge of finance, communications, facilities, GMP, and IT and raised over $400 million in public and private financings.
"Nathan's highly differentiated background integrates operational and strategic leadership, a deep understanding of value creation in the life sciences, and expertise in neuroscience, which will be critical as we advance additional programs into the clinic and build a multi-modality neurotherapeutics company," said Alfred W. Sandrock, Chief Executive Officer of Voyager.
For comments and feedback contact: editorial@rttnews.com
Business News
June 05, 2026 16:18 ET A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.